Acomplia (rimonabant), a promising new drug for obesity, smoking cessation, and high cholesterol

Researchers are excited about Acomplia (rimonabant), a promising new drug for obesity, smoking cessation, and high cholesterol.

The lay press has picked up on this too-good-to-be-true drug, and people are asking about it.

It's the first in a new class...called selective cannabinoid type 1 (CB1) blockers.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote